ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.

Valentina R Garbarino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.